Dial-in Number

  • One tap mobile
    +13126266799,,3231998494# US (Chicago)
    +13462487799,,3231998494# US (Houston)
  • Dial by your location
    +1 312 626 6799 US (Chicago)
    +1 346 248 7799 US (Houston)
    +1 669 900 6833 US (San Jose)
    +1 929 436 2866 US (New York)
    +1 253 215 8782 US
    +1 301 715 8592 US
    Meeting ID: 323 199 8494
    Find your local number:

Web session

HL7 Antitrust Policy

Professional Associations, such as HL7, which bring together competing entities are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of the Governance and Operations Manual (GOM).


Melva Peters (Chair)Jenaker Consulting
John HatemIndependent Consultant
Isaac VetterEpic
Christof GessnerHL7 Germany
Shelly SpiroPharmacy HIT Collaborative
Brad WiseHumana
Stephen ChuADHA
Danielle Bancroft
Corey SpearsMITRE
Frank McKinneyPOCP
Dave HillMITRE
Peter SergentHL7 New Zealand
Scott robertson
Joe Quinn

Agenda Items and Notes

Meeting Notes from previous meeting

Project Review

Project Proposals

Project Scope Statements

Discussion of MedicationKnowledge changes (Jean Duteau)

  • - no discussion

Catalog Updates (John Hatem)

  • - no meeting last week; next meeting Dec 3, 2021

Workflow Update (John Hatem) 

  • - no meeting today, next meeting Dec 6, 2021

Healthcare Product Update (John Hatem)

    • discussed device Jira's - no pharmacy impact
    • Insulin and IVIG are not Biologically Derived Products

NCPDP Updates (NCPDP Members)


Global Supply Chain Project (Scott)


Medication List Guidance project (John)

  • - no updates this week


Pharmacy Templates

  • waiting for requirements from Christof and then will decide on next steps for new version
  • Still waiting for approval of change request in Europe
    • additional elements to be added - part relationship

PDex Formulary (Corey)

  • Approval of IG for ballot - vote November 29
  • Bulk Data change - not specifically included in the scope of the PSS - but PSS is not specific to formulary
    • Need to look at the scope of the PSS to be clear about what the PSS is about

Medication List Project from EHR 



FHIR (Group)

BR&R managed resources review

  • no recent meetings

New Resource - FormularyItem

  • January 21 - new resource proposal deadline for May 2022 ballot

Preparation for Normative

  • Melva to work with John about QA needed

Trackers - link to pharmacy unresolved Jira trackers (see trackers for details / resolutions)

Any Other Business

Next meeting

  • December 6, 2021